Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mizuho Kittaka

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Bone Reports|April 8, 2020
RANKL-independent osteoclastogenesis in the SH3BP2 cherubism miceMizuho Kittaka, Tetsuya Yoshimoto, Henry Hoffman, et al.
Frontiers in Bioinformatics|April 27, 2022
OC_Finder: Osteoclast segmentation, counting, and classification using watershed and deep learningXiao Wang, Mizuho Kittaka, Yilin He, et al.
Bone|December 3, 2014
Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism miceTeruhito Yoshitaka, Mizuho Kittaka, Shu Ishida, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 19, 2018
Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse ModelTetsuya Yoshimoto, Tatsuhide Hayashi, Toshio Kondo, et al.
JBMR Plus|March 20, 2024
Inhibition of RANKL improves the skeletal phenotype of adenine-induced chronic kidney disease in miceCorinne E Metzger, Mizuho Kittaka, Alec N LaPlant, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 1, 2014
Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-α-induced inflammation and bone lossTeruhito Yoshitaka, Shu Ishida, Tomoyuki Mukai, et al.
Journal of Immunological Methods|March 10, 2017
A novel gingival overgrowth mouse model induced by the combination of CsA and ligature-induced inflammationAi Okanobu, Shinji Matsuda, Mikihito Kajiya, et al.
Journal of Periodontology|July 23, 2022
Type 1 diabetes mellitus leads to gingivitis and an early compensatory increase in bone remodelingXue Yuan, Vedanshi Amin, Tianli Zhu, et al.
JBMR Plus|June 16, 2020
Microbe-Dependent Exacerbated Alveolar Bone Destruction in Heterozygous Cherubism MiceMizuho Kittaka, Tetsuya Yoshimoto, Collin Schlosser, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 16, 2017
Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ OsteoclastsMizuho Kittaka, Kotoe Mayahara, Tomoyuki Mukai, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Bone Reports|April 8, 2020
RANKL-independent osteoclastogenesis in the SH3BP2 cherubism miceMizuho Kittaka, Tetsuya Yoshimoto, Henry Hoffman, et al.
Frontiers in Bioinformatics|April 27, 2022
OC_Finder: Osteoclast segmentation, counting, and classification using watershed and deep learningXiao Wang, Mizuho Kittaka, Yilin He, et al.
Bone|December 3, 2014
Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism miceTeruhito Yoshitaka, Mizuho Kittaka, Shu Ishida, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 19, 2018
Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse ModelTetsuya Yoshimoto, Tatsuhide Hayashi, Toshio Kondo, et al.
JBMR Plus|March 20, 2024
Inhibition of RANKL improves the skeletal phenotype of adenine-induced chronic kidney disease in miceCorinne E Metzger, Mizuho Kittaka, Alec N LaPlant, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 1, 2014
Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-α-induced inflammation and bone lossTeruhito Yoshitaka, Shu Ishida, Tomoyuki Mukai, et al.
Journal of Immunological Methods|March 10, 2017
A novel gingival overgrowth mouse model induced by the combination of CsA and ligature-induced inflammationAi Okanobu, Shinji Matsuda, Mikihito Kajiya, et al.
Journal of Periodontology|July 23, 2022
Type 1 diabetes mellitus leads to gingivitis and an early compensatory increase in bone remodelingXue Yuan, Vedanshi Amin, Tianli Zhu, et al.
JBMR Plus|June 16, 2020
Microbe-Dependent Exacerbated Alveolar Bone Destruction in Heterozygous Cherubism MiceMizuho Kittaka, Tetsuya Yoshimoto, Collin Schlosser, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 16, 2017
Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ OsteoclastsMizuho Kittaka, Kotoe Mayahara, Tomoyuki Mukai, et al.
Pageof 3